NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-136-2016-1-US-03 Imageable Polymers, Methods of Making and Methods of Use Thereof US National Stage 16/349,458 11382990 Issued PDF
NCI E-174-2012-0-US-03 METHODS OF PRODUCING T MEMORY STEM CELL POPULATIONS US DIV 16/410,327 11111478 Issued PDF
NCI E-070-2015-0-US-06 Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15) US CON 16/411,062 Pending
NCATS E-095-2018-0-PCT-02 QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS PCT PCT PCT/US2019/31987 Expired
NCI E-508-2013-2-CN-12 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE CN DIV 201910393592.0 Issued
NCI E-495-2013-0-US-11 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS US CON 16/408,939 10913785 Issued PDF
NIMH E-259-2016-0-US-04 Radiolabeling Agents, Methods of Making, and Methods of Use Thereof US National Stage 16/349,124 Abandoned
NEI E-293-2016-0-US-03 TISSUE CLAMP AND IMPLANTATION METHOD US National Stage 16/348,855 11717298 Issued PDF
NIAID E-053-2018-1-US-02 Methods Of Treating And Inhibiting Ebola Virus Infection US National Stage 16/348,867 11617753 Issued PDF
NCI E-075-2018-0-PCT-01 HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES PCT PCT COMB PCT/US2019/031356 Expired
NEI E-004-2017-0-US-03 3D VASCULARIZED HUMAN OCULAR TISSUE FOR CELL THERAPY AND DRUG DISCOVERY US National Stage 16/347,939 11458225 Issued PDF
NCI E-169-2016-0-AU-03 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS AU National Stage 2017355564 Issued
NCI E-022-2017-0-US-04 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US National Stage 16/347,778 11312998 Issued PDF
NCI E-169-2016-0-US-06 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS US National Stage 16/347,764 11311613 Issued PDF
NCI E-022-2017-0-FR-06 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT FR EP 17805342.7 Issued
NCI E-022-2017-0-DE-07 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT DE EP 17805342.7 Issued
NCI E-022-2017-0-EP-03 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT EP National Stage 17805342.7 Issued
NCI E-022-2017-0-GB-08 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT GB EP 17805342.7 Issued
NIAID E-357-2001-1-AU-31 WEST NILE VIRUS AND DENGUE 4 VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS AU DIV 2019203166 Expired
NCI E-123-2018-0-EP-03 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF EP National Stage 19724994.9 Issued
NEI E-293-2016-0-AU-04 TISSUE CLAMP AND IMPLANTATION METHOD AU National Stage 2017359336 Issued
NIAID E-239-2014-0-US-07 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US DIV 16/403,211 10759846 Issued PDF
NCI E-123-2018-0-PCT-02 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF PCT PCT PCT/US2019/030656 Expired
NIAID E-079-2018-0-PCT-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION PCT PCT COMB PCT/US2019/030431 Expired
NIAID E-079-2018-0-EP-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION EP National Stage 19724039.3 Pending
NCI E-098-2018-0-PCT-02 T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR PCT PCT PCT/US2019/030108 Expired
NIEHS E-125-2018-2-EP-03 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS EP National Stage 19723298.6 Issued
NCI E-040-2012-0-AU-32 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2019203042 Issued
NIEHS E-125-2018-2-PCT-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS PCT PCT COMB PCT/US2019/29801 Expired
NIEHS E-125-2018-2-CN-05 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS CN National Stage 201980029352.0 Pending
NHLBI E-287-2015-0-US-03 Device, Prosthesis And Delivery Systems, Transcatheter MRI-guided Implantable Cavopulmonary Bypass Endograft US CON 16/399,670 Pending
NCI E-103-2021-0-PCT-02 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS PCT PCT PCT/US2019/029639 Expired
NCI E-765-2013-0-US-08 MULTIFUNCTIONAL RNA NANOPARTICLES AND METHODS OF USE US CON 16/397,534 Abandoned
NCI E-103-2021-0-EP-01 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS EP DIV 23190055.6 Pending
NCI E-188-2016-0-US-03 STABLE WATER ISOTOPE LABELING AND MAGNETIC RESONANCE IMAGING FOR VISUALIZATION OF RAPIDLY DIVIDING CELLS US National Stage 16/345,612 11684306 Issued PDF
NIDCR E-142-2011-0-US-10 AAV MEDIATED EXENDIN-4 GENE TRANSFER TO SALIVARY GLANDS TO PROTECT SUBJECTS FROM DIABETES OR OBESITY US DIV 16/396,262 11207361 Issued PDF
NIMH E-126-2018-0-PCT-02 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF PCT PCT PCT/US2019/029285 Expired
NIMH E-126-2018-0-EP-04 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF EP National Stage 19722432.2 Abandoned
NIMH E-345-2013-0-AU-07 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches AU DIV 2019202928 Abandoned
NIAID E-215-2016-1-US-03 PREFUSION PIV F IMMUNOGENS AND THEIR USE US National Stage 16/344,772 11078239 Issued PDF
NCI E-266-2011-0-HK-34 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage HK EP 19122845.1 Issued
NIAID E-234-2016-1-US-03 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US National Stage 16/344,774 10960070 Issued PDF
NIAID E-051-2002-0-US-19 METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND
ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND
INFLAMMATION 		US CON 16/391,423 11471528 Expired PDF
NCI E-750-2013-0-EP-11 Methods for Subtyping Lymphoma Types by Means of Expression Profiling EP DIV 19170689.4 Issued
NCI E-750-2013-0-GB-24 Methods for Subtyping Lymphoma Types by Means of Expression Profiling GB EP 19170689.4 Issued
NCI E-750-2013-0-ES-22 Methods for Subtyping Lymphoma Types by Means of Expression Profiling ES EP 19170689.4 Issued
NCI E-750-2013-0-FR-23 Methods for Subtyping Lymphoma Types by Means of Expression Profiling FR EP 19170689.4 Issued
NCI E-750-2013-0-DE-21 Methods for Subtyping Lymphoma Types by Means of Expression Profiling DE EP 19170689.4 Issued
NIAID E-018-2018-0-PCT-02 CHIMERIC VECTORS PCT PCT PCT/US2019/028771 Expired
NCI E-122-2018-0-PCT-02 COMPOSITIONS AND METHODS FOR MODULATINGvENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION PCT PCT PCT/US2019/028690 Expired